• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guide regarding choice of second-line therapy to obtain a high cumulative cure rate.

作者信息

Graham David Y, Calvet Xavier

出版信息

Helicobacter. 2012 Aug;17(4):243-5. doi: 10.1111/j.1523-5378.2012.00952.x. Epub 2012 Apr 8.

DOI:10.1111/j.1523-5378.2012.00952.x
PMID:22759322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3993082/
Abstract
摘要

相似文献

1
Guide regarding choice of second-line therapy to obtain a high cumulative cure rate.关于选择二线治疗以获得高累积治愈率的指南。
Helicobacter. 2012 Aug;17(4):243-5. doi: 10.1111/j.1523-5378.2012.00952.x. Epub 2012 Apr 8.
2
A new second-line sequential regimen for Helicobacter pylori eradication based on levofloxacin: a pilot study.一种基于左氧氟沙星的根除幽门螺杆菌的新型二线序贯疗法：一项试点研究。
Dig Dis Sci. 2010 Dec;55(12):3630-1. doi: 10.1007/s10620-010-1199-0.
3
Recurrence of Helicobacter pylori After Eradication in Patients with Peptic Ulcer.
South Med J. 2012 Jun;105(6):322-3. doi: 10.1097/SMJ.0b013e318257c6f8.
4
Levofloxacin in first-line treatment of Helicobacter pylori infection.
Helicobacter. 2007 Aug;12(4):364-5. doi: 10.1111/j.1523-5378.2007.00517.x.
5
Treatment of Helicobacter pylori infection: the past and the future.幽门螺杆菌感染的治疗：过去与未来。
Eur J Intern Med. 2010 Oct;21(5):357-9. doi: 10.1016/j.ejim.2010.07.009. Epub 2010 Aug 1.
6
Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence?
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1283-5; author reply 1285-6. doi: 10.1111/j.1365-2036.2006.02857.x.
7
Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.信函：在两次根除幽门螺杆菌感染治疗失败后使用左氧氟沙星进行三线挽救治疗。
Aliment Pharmacol Ther. 2012 Jun;35(12):1484-5; author reply 1486. doi: 10.1111/j.1365-2036.2012.05117.x.
8
Rescue therapy with levofloxacin after multiple H. pylori treatment failures.
Aliment Pharmacol Ther. 2005 Oct 1;22(7):653-4; author reply 654-5. doi: 10.1111/j.1365-2036.2005.02622.x.
9
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.左氧氟沙星/阿莫西林为基础的方案与四联疗法在二线治疗幽门螺杆菌根除的比较。
World J Gastroenterol. 2012 Oct 28;18(40):5669-78. doi: 10.3748/wjg.v18.i40.5669.
10
Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.幽门螺杆菌感染：序贯疗法继以含左氧氟沙星的三联疗法可提供良好的累积根除率。
Helicobacter. 2012 Aug;17(4):246-53. doi: 10.1111/j.1523-5378.2012.00945.x. Epub 2012 Mar 20.

引用本文的文献

1
High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of infection - A review of the strengths, weaknesses, and proposed solutions.高剂量双联疗法与含铋四联疗法治疗感染的比较——优势、劣势及解决方案综述
Tzu Chi Med J. 2021 Nov 15;34(3):303-309. doi: 10.4103/tcmj.tcmj_185_21. eCollection 2022 Jul-Sep.
2
Illusions regarding clinical trials and treatment guidelines.关于临床试验和治疗指南的错觉。
Gut. 2017 Dec;66(12):2043-2046. doi: 10.1136/gutjnl-2017-314744. Epub 2017 Sep 21.
3
Efficacy of Clarithromycin Containing Bismuth-Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication.含克拉霉素的铋剂方案作为二线疗法根除幽门螺杆菌的疗效
Middle East J Dig Dis. 2015 Apr;7(2):75-81.
4
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China.含铋四联疗法治疗幽门螺杆菌：来自中国的经验。
Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1134-40. doi: 10.1097/MEG.0b013e3283633b57.
5
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.合理的幽门螺杆菌治疗：基于证据的医学，而不是基于证据的医学。
Clin Gastroenterol Hepatol. 2014 Feb;12(2):177-86.e3; Discussion e12-3. doi: 10.1016/j.cgh.2013.05.028. Epub 2013 Jun 8.

本文引用的文献

1
Therapy in the West.西方的治疗方法。
Jpn J Helicobacter Res. 2012;13(2):4-9.
2
Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.幽门螺杆菌感染：序贯疗法继以含左氧氟沙星的三联疗法可提供良好的累积根除率。
Helicobacter. 2012 Aug;17(4):246-53. doi: 10.1111/j.1523-5378.2012.00945.x. Epub 2012 Mar 20.
3
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.随机试验：埃索美拉唑、莫西沙星和阿莫西林二线或补救治疗幽门螺杆菌感染的 14 天与 7 天疗程比较。
Helicobacter. 2011 Dec;16(6):420-6. doi: 10.1111/j.1523-5378.2011.00867.x.
4
Optimal therapy for Helicobacter pylori infections.幽门螺杆菌感染的最佳治疗方法。
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):79-88. doi: 10.1038/nrgastro.2010.210.
5
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.莫西沙星和左氧氟沙星三联疗法作为幽门螺杆菌持续感染二线治疗的优势：一项荟萃分析。
Wien Klin Wochenschr. 2010 Jul;122(13-14):413-22. doi: 10.1007/s00508-010-1404-3. Epub 2010 Jul 16.
6
Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.采用马斯特里赫特Ⅲ共识提出的一线和二线治疗方案以及三线经验性治疗方案后，临床实践中幽门螺杆菌的累积根除率。
Am J Gastroenterol. 2009 Jan;104(1):21-5. doi: 10.1038/ajg.2008.87.
7
A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.一项基于社区的幽门螺杆菌治疗研究，采用检测、治疗、复查和对初始治疗失败进行再治疗的策略。
Helicobacter. 2006 Oct;11(5):418-24. doi: 10.1111/j.1523-5378.2006.00432.x.
8
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.基于左氧氟沙星的三联疗法与基于铋剂的四联疗法治疗幽门螺杆菌持续感染的Meta分析
Am J Gastroenterol. 2006 Mar;101(3):488-96. doi: 10.1111/j.1572-0241.2006.00637.x.
9
Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.荟萃分析：与一线抗幽门螺杆菌四联疗法相关的疗效、不良事件及依从性
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1071-82. doi: 10.1111/j.1365-2036.2004.02248.x.
10
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.幽门螺杆菌感染管理的当前概念——《马斯特里赫特2-2000共识报告》
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. doi: 10.1046/j.1365-2036.2002.01169.x.